Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02877810 · ClinicalTrials.gov registry record · NA

Evidence-Based Tele-Emergency Network Grant Program

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
696
Enrollment target

NCT02877810: Completed NA study, sponsored by University of California, Davis.

NCT02877810 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 696 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02877810, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
696 participants
Enrollment target

Study Summary

The purpose of this study is to determine the impact of an existing tele-emergency care network on quality of care, appropriateness of care utilization, patient safety (medication errors), and cost effectiveness compared to telephone consultations from a healthcare system prospective.

Primary Outcome

The investigators hypothesize that children receiving care in EDs during periods of telemedicine use will receive higher quality of care than similar children who receive care during periods of telephone use. A previously validated 5-item implicit review instrument that measures 4 aspects of process of care in the ED, along with a fifth item assessing the overall quality of care provided to the patient will be used. The sum of the 5 item-specific scores will be aggregated from each reviewer to o

Interventions

  • OTHER Telemedicine
  • OTHER Telephone

Trial Details

FieldValue
Enrollment Target 696 participants
Start Date 2015-11
Est. Completion 2019-08
Phase NA
University of California, Davis

657 total trials

What the finished NCT02877810 record still lists

NCT02877810 is an interventional study that assigns participants to a tested intervention. The registered 696 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 2 interventions - of which Telemedicine is the first listed.

NCT02877810 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02877810 about?

NCT02877810 is a clinical study titled "Evidence-Based Tele-Emergency Network Grant Program". The purpose of this study is to determine the impact of an existing tele-emergency care network on quality of care, appropriateness of care utilization, patient safety (medication errors), and cost effectiveness compared to telephone consultations from a healthcare system prospective.

What is the current status of trial NCT02877810?

This trial is currently completed. It is a NA study. The enrollment target is 696 participants. The study started on 2015-11. Estimated completion is 2019-08.

What interventions are being tested in trial NCT02877810?

The interventions under investigation include: Telemedicine (OTHER), Telephone (OTHER).

Who is sponsoring clinical trial NCT02877810?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02877810's enrollment target sits among peer trials

696 151st of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05417594 · 695 participants · Phase 1

    Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • NCT06801834 · 695 participants · Phase 3

    Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  • NCT03136094 · 698 participants · NA

    Suicide in Urban Natives: Detection and Networks to Combat Events

  • NCT04928846 · 698 participants · Phase 3

    A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02877810, the US trial registry maintained by the National Library of Medicine. NCT02877810 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.